Stability of rare TP53 co-mutations in AML patients. CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission ...
In the United States, cancer centers commonly advertise their services to the public. Several benefits from such advertising exist that include patient education of cancer treatment options and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results